DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2023
    • Call for Papers
    • Sponsor and Exhibit
    • New Researcher Network
    • Conference Logistics
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2022
      • APS Workshop
      • Conference Papers
      • DDL2022 Programme
      • DDL2022 Speakers
      • DDL2022 Sponsors
      • DDL2022 Photo Album
    • DDL2021
      • Conference Papers
      • DDL2021 Programme
      • DDL2021 Speakers
      • DDL2021 Sponsors
    • DDL2020
      • Conference Papers
      • Speakers and Lecture Recordings
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2019 Photo Album
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2018 Photo Album
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2017 Photo Album
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • Associated Events
    • EPSRC CDT in Aerosol Science Annual Conference 2023
    • ERS International Congress 2023
    • ISAM Congress 2023
    • RDD Europe 2023
  • Contact
  • The Aerosol Society logo
Felix Wiegandt :

Felix Wiegandt

Fraunhofer Institute for Toxicology and Experimental Medicine

Paper: Novel Highly Efficient System for Breath-Triggered Aerosol Delivery for Preterm Infants using Non-Contact Breath Capture

Felix Wiegandt completed his bachelor's degree in mechanical engineering in 2013 and his master's degree in biomedical engineering in 2015 at Leibniz University Hannover. In 2022, Felix successfully completed his doctorate in mechanical engineering at Technische Universität Braunschweig.

Since 2014, Felix has been working at Fraunhofer Institute for Toxicology and Experimental Medicine in Hannover, specializing in a breath-triggered drug delivery system for (pre)term infants. He developed a system that allows the release of an aerosol in a breath-triggered manner to preterm infants, achieving great improvements which far surpass the standard used in the clinic in terms of efficiency. In order to utilize this system in the clinic, it is currently being further developed within the framework of the EU project MDOT (Medical Device Obligations Taskforce), with the goal of a completed clinical study on breath-triggered aerosol release in preterm infants by 2023.

With several publications and international patents under his belt, Felix knows the importance of driving innovation; therefore, the breath-triggered drug delivery technology is planned to be spun-off into a start-up company.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2023 Drug Delivery to the Lungs Website design: definingdesign.co.uk